fda compounding semaglutide warning letters october 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Congress Introduces SAFE Drugs Act

But when your appetite drops, it can also become harder to get the nutrition your body still needs

As adoption and adherence grows, plan sponsors are keeping a close watch on clinical benefits and long-term financial impact

It will be up to insurers to decide if they want to cover retatrutide prescriptions once it is FDA approved

Advantages include a clear side effect profile, since any reactions are attributable to semaglutide alone rather than combination ingredients

Step 2: selection of an appropriate starting tirzepatide dose Many patients begin at a lower tirzepatide dose to improve tolerance

To qualify, you must be 18 or older, participate in the Medicare part D drug coverage program and meet certain health criteria: Have a BMI thats 35 or higher, the threshold for severe obesity Have a BMI between 27 and 34.9 and at least one of the specified obesity-associated health complications for your weight and height Bridge is an experiment